Instead of just investing its insurance float, Apollo seeds origination platforms and raises outside capital. This structure applies fee-and-carry economics to the deals, effectively multiplying the return potential of its initial insurance capital.

Fairfax strategically over-reserves in its insurance businesses. This defers income, reduces current tax liabilities, and creates a conservative balance sheet where future equity is embedded in the reserves, which can be released later, even against auditor pressure.

While a soft market slows premium growth, it also reduces the need for capital to back new business. This frees up significant cash flow for Fairfax to execute accretive buybacks and other capital returns, especially when the stock trades at a discount to its intrinsic value.

Fairfax follows a clear capital allocation framework. They prioritize open market buybacks when the stock is below 1.5 times price-to-book. Above that multiple, they shift capital towards closing out their Total Return Swaps, providing a predictable approach for investors.

After enduring a brutal multi-year short-seller campaign, Fairfax concluded that a fortress balance sheet is the ultimate defense. They now hold billions in cash and untapped credit lines, not just for operational safety, but specifically to make the company an unattractive target for future hedge fund attacks.

The book "The Fairfax Way" reveals the company's early success wasn't merely from acquiring insurers at low valuations. The critical, often overlooked element was the immense time, money, and work required to revamp and stabilize these acquired operations to an acceptable level, a key lesson for value investors.

Fairfax's multi-billion dollar gain during the 2008 crisis was not a speculative macro bet but a defensive one. They bought credit default swaps (CDS) as insurance against their own reinsurers, whom they identified as being dangerously exposed to mortgage-backed securities, protecting themselves from counterparty failure.

The true value of Fairfax's holdings is understated due to accounting rules for large equity stakes (like Eurobank) and unconsolidated JVs. The realizable book value is estimated to be over $1500 per share versus the stated ~$1260, creating a significant hidden asset for investors.

Unlike Berkshire Hathaway's "buy and hold forever" approach, Fairfax partners with management teams and is often willing to sell a business if the managers decide it's the right time. This flexibility provides an additional tool for deal-making and capital recycling.